Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion

Friday, December 11, 2020

Boehringer Ingelheim today announced the signing of a binding agreement for acquiring all shares of NBETherapeutics a private clinicalstage Swiss biotechnology company focused on antibodydrug conjugates and advancing targeted cancer therapies derived...

Arcus Biosciences Expands Strategic Relationship with WuXi Biologics to Develop a Best-in-Class anti-CD39 Antibody for the Treatment of Cancer

Thursday, December 10, 2020

Arcus Biosciences Inc an oncologyfocused biopharmaceutical company working to create bestinclass cancer therapies and WuXi Biologics HK a global company with leading openaccess biologics technology platforms announced an expansion of their existing s...

InveniAI and Kyowa Kirin Enter AI-Powered Novel Target Discovery Collaboration

Thursday, December 10, 2020

InveniAI LLC a global leader in pioneering the application of artificial intelligence AI and machine learning ML to transform innovation across drug discovery and development and Kyowa Kirin Co Ltd Kyowa Kirin TSE a global specialty pharmaceutical co...

Applied BioMath, LLC Announces Collaboration with Antengene for Systems Pharmacology Modeling in Oncology

Wednesday, December 09, 2020

Applied BioMath wwwappliedbiomathcom the industryleader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development today announced a collaboration with Antengene Corporation for the devel...

Intec Pharma Announces Cannabinoid Research Collaboration with GW Pharma

Wednesday, December 09, 2020

Intec Pharma Ltdannounces it has entered into a feasibility agreement with GW Research Limited GW London UK to explore using the Accordion Pill AP platform for an undisclosed research programWe are very excited to collaborate with GW said Jeffrey A M...

Aligos Enters into an Exclusive License and Research Collaboration Agreement with Merck to Discover and Develop an Oligonucleotide Therapy for NASH

Tuesday, December 08, 2020

Aligos Therapeutics Incannounced that it has entered into an Exclusive License and Research Collaboration Agreement with Merck known as MSD outside the United States and Canada under which Merck and Aligos will apply Aligos oligonucleotide platform t...

PostEra enters into strategic alliance with Pfizer Inc. to advance drug discovery

Tuesday, December 08, 2020

PostEra a biotechnology company specializing in machine learning solutions for preclinical drug discovery announced a strategic alliance with Pfizer Inc NYSE PFE with the goal of to accelerate the discovery of small molecule drugs by developing a p...

Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors

Monday, December 07, 2020

Bayer and Atara Biotherapeutics Inc announced an exclusive worldwide license agreement and research development and manufacturing collaboration for mesothelindirected CAR Tcell therapies for the treatment of solid tumors

Y-mAbs and Takeda Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) and Omburtamab in Israel

Saturday, December 05, 2020

YmAbs Therapeutics Inc a commercialstage biopharmaceutical company focused on the development and commercialization of novel antibodybased therapeutic products for the treatment of cancer and Takeda Israel a wholly owned subsidiary of Takeda Pharmace...

Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies

Friday, December 04, 2020

Tevard Biosciences a privatelyheld biotechnology company pioneering tRNAbased gene therapies and Zogenix a global biopharmaceutical company developing and commercializing rare disease therapies announced that the companies have entered into a collabo...